regulation
MHRA Grants Licence for New UK-Manufactured CBD Medicine
The MHRA has granted its first marketing authorisation for a CBD medicine manufactured entirely in the UK, produced by Celadon Pharmaceuticals at its.
Celadon Pharmaceuticals has received regulatory approval for its anxiety-indication CBD formulation, becoming the first company to achieve full MHRA licensing for a UK-manufactured cannabis medicine. The company cultivates pharmaceutical-grade cannabis at a GMP-certified facility in Hampshire and has applied for NHS reimbursement in parallel with the commercial launch.
More Regulation News
Regulation
Bedrocan Expands UK Distribution Network
Dutch pharmaceutical cannabis producer Bedrocan has announced a significant expansion of its UK distribution network, p…
26 May 2026
Regulation
UK Government Confirms Medical Cannabis Not Moving to Schedule 2
The UK government has confirmed that medical cannabis will remain under Schedule 1 of the Misuse of Drugs Regulations, …
25 May 2026
Regulation
Medical Cannabis Prescription Process to Be Streamlined by NHSE
NHS England has announced plans to streamline the medical cannabis prescription process, including the introduction of …
21 May 2026
More News
product
Adven EMT-3: UK Availability, Price and Prescribing Guide
07 Jun 2026
product
Bedrolite CBD Oil UK: Prices, Availability and Patient Guide
07 Jun 2026
news
Alternaleaf UK: Full Product List, Prices and Patient Review 2026
07 Jun 2026
regulation
Bedrocan Expands UK Distribution Network
26 May 2026